Integer Holdings Corporation is set to make a significant impact at MD&M West 2025, taking place from February 4th to 6th at the Anaheim Convention Center. As a leading global medical device CDMO, Integer will demonstrate its commitment to advancing patient care through innovative technologies and comprehensive manufacturing solutions.
Showcasing Advanced Medical Technologies
At booth #1439, Integer will present a wide array of capabilities tailored for cardio and vascular, cardiac rhythm management, and neuromodulation products. The exhibit will feature state-of-the-art technologies that integrate expertise and resources to support clients in accelerating product development and minimizing market entry risks. Additionally, the company will highlight its global rapid prototyping services, offering clients a seamless experience with as little as a two-week turnaround for specialized cardiovascular prototypes, including catheter shafts, guidewires, and steerable sheaths.
Strategic Acquisitions Enhance Service Offerings
Integer will also introduce attendees to Pulse Technologies at booth #2854, showcasing HSR technology and complex micro machining capabilities essential for critical medical device components. Furthermore, the recent acquisition of Precision Coating, completed for $152 million, expands Integer’s portfolio with advanced surface coating technologies. This strategic move strengthens Integer’s ability to meet evolving customer needs by incorporating proprietary coating solutions that enhance product performance and reliability.
Inferences:
- Integer is expanding its global footprint through strategic acquisitions and enhanced service offerings.
- The focus on rapid prototyping indicates a commitment to reducing time-to-market for medical devices.
- Integration of Precision Coating suggests a move towards more comprehensive and high-value manufacturing solutions.
Integer’s participation in MD&M West 2025 underscores its role as a key player in the medical device industry. By showcasing a diverse range of technologies and solutions, the company demonstrates its ability to support clients at every stage of product development. The acquisition of Precision Coating not only broadens Integer’s technical capabilities but also positions the company to better serve the dynamic needs of the medical device market. Attendees can expect to see firsthand how Integer’s collaborative approach and strategic investments are driving innovation and quality in medical device manufacturing.

This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.